Live-attenuated LCMV-based vector for active immunotherapy of HPV16+cancer

被引：0
|
作者：
Schmidt, Sarah
ElGazzar, Ahmed
Bonilla, Weldy V.
Pauzuolis, Mindaugas
Reiter, Andrea
Kleissner, Theresa
Oeler, Daniel
Stemeseder, Felix
Berka, Ursula
Kiefmann, Bettina
Schulha, Sophie
Matushansky, Igor
Merkler, Doron
Pinschewer, Daniel
Orlinger, Klaus
机构：
[1] Hookipa Pharma Inc, Vienna, Austria
[2] Univ Basel, Basel, Switzerland
[3] Geneva Univ Hosp, Div Clin Pathol, Geneva, Switzerland
[4] Hookipa Pharma Inc, New York, NY USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR18-B131
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B131
引用
收藏
页数：2
相关论文
共 20 条
  • [1] Live-attenuated LCMV-based vector for active immunotherapy of HPV16+cancer.
    Schmidt, Sarah
    Bonilla, Weldy V.
    Pauzuolis, Mindaugas
    Reiter, Andrea
    Kleissner, Theresa
    Oeler, Daniel
    Stemeseder, Felix
    Berka, Ursula
    Kiefmann, Bettina
    Schulha, Sophie
    Matushansky, Igor
    Merkler, Doron
    Pinschewer, Daniel
    Orlinger, Klaus Karl
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancer
    Schmidt, Sarah
    Bonilla, Weldy, V
    Reiter, Andrea
    Stemeseder, Felix
    Kleissner, Theresa
    Oeler, Daniel
    Berka, Ursula
    EI-Gazzar, Ahmed
    Kiefmann, Bettina
    Schulha, Sophie C.
    Raguz, Josipa
    Habbeddine, Mohamed
    Scheinost, Marilies
    Qing, Xiaoping
    Lauterbach, Henning
    Matushansky, Igor
    Pinschewer, Daniel D.
    Orlinger, Klaus K.
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [3] Live-attenuated bacteria as a cancer vaccine vector
    Toussaint, Bertrand
    Chauchet, Xavier
    Wang, Yan
    Polack, Benoit
    Le Gouellec, Audrey
    EXPERT REVIEW OF VACCINES, 2013, 12 (10) : 1139 - 1154
  • [4] Live-attenuated Listeria-based immunotherapy
    Rothman, John
    Paterson, Yvonne
    EXPERT REVIEW OF VACCINES, 2013, 12 (05) : 493 - 504
  • [5] Targeting the receptor tyrosine kinase EphA2 with a live-attenuated Listeria monocytogenes-based active immunotherapy
    Straley, Erin
    Moody, Gordon
    Hammond, Scott
    Brockstedt, Dirk
    Luckett, William
    Gao, Yi
    Giedlin, Martin
    Kiener, Peter
    Kinch, Michael
    Cook, David
    Dubensky, Tom
    Bruckheimer, Elizabeth
    CANCER RESEARCH, 2006, 66 (08)
  • [6] Constitutive activation of the PrfA regulon enhances the potency of vaccines based on live-attenuated and killed but metabolically active Listeria monocytogenes strains
    Lauer, Peter
    Hanson, Bill
    Lemmens, Edward E.
    Liu, Weiqun
    Luckett, William S.
    Leong, Meredith L.
    Allen, Heather E.
    Skoble, Justin
    Bahjat, Keith S.
    Freitag, Nancy E.
    Brockstedt, Dirk G.
    Dubensky, Thomas W., Jr.
    INFECTION AND IMMUNITY, 2008, 76 (08) : 3742 - 3753
  • [7] Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer
    Charles G. Drake
    Russell K. Pachynski
    Sumit K. Subudhi
    Douglas G. McNeel
    Emmanuel S. Antonarakis
    Todd M. Bauer
    Peter Lauer
    Dirk Brockstedt
    Daniel Patricia
    Mark Wade
    Enrique Zudaire
    Nibedita Bandyopadhyay
    Dolly A. Parasrampuria
    Suzette Girgis
    Gary E. Mason
    Roland E. Knoblauch
    Nicole Stone
    Jeffrey R. Infante
    Marco M. Gottardis
    Lawrence Fong
    Prostate Cancer and Prostatic Diseases, 2022, 25 : 219 - 228
  • [8] Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer
    Drake, Charles G.
    Pachynski, Russell K.
    Subudhi, Sumit K.
    McNeel, Douglas G.
    Antonarakis, Emmanuel S.
    Bauer, Todd M.
    Lauer, Peter
    Brockstedt, Dirk
    Patricia, Daniel
    Wade, Mark
    Zudaire, Enrique
    Bandyopadhyay, Nibedita
    Parasrampuria, Dolly A.
    Girgis, Suzette
    Mason, Gary E.
    Knoblauch, Roland E.
    Stone, Nicole
    Infante, Jeffrey R.
    Gottardis, Marco M.
    Fong, Lawrence
    PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (02) : 219 - 228
  • [9] A phase 2 study of live-attenuated listens monocytogenes cancer immunotherapy (ADXS11-001) in the treatment of persistent or recurrent cancer of the cervix (GOG-0265).
    Huh, Warner King
    Brady, William E.
    Moore, Kathleen N.
    Lankes, Heather A.
    Monk, Bradley J.
    Aghajanlan, Carol
    Dizon, Don S.
    Armstrong, Deborah K.
    Thaker, Premal H.
    Fracasso, Paula M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] A phase II study of live-attenuated Listeria monocytogenes immunotherapy (ADXS11-001) in the treatment of persistent or recurrent cancer of the cervix (GOG-0265)
    Huh, Warner King
    Brady, William E.
    Moore, Kathleen N.
    Lankes, Heather A.
    Monk, Bradley J.
    Aghajanian, Carol
    Dizon, Don S.
    Fracasso, Paula M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12